Merck To Close Plant In South Korea As Part Of Global Supply Strategy
This article was originally published in PharmAsia News
SHANGHAI - Merck will close down its plant in South Korea, the U.S.-based drug maker said Nov. 3
You may also be interested in...
TOKYO - Merck subsidiary Banyu Pharmaceutical, said Oct. 23 it would close its research laboratory in Tsukuba City, northeast of Tokyo, by the end of 2009, leaving only a fraction of foreign drug makers with basic research activities in Japan
Asia Partnerships Critical To Big Pharma’s Drying Pipelines, Merck Exec Tells Bio Korea (Part 2 of 2)
[Editor's note: This is part two of a two-part story from Bio Korea; part one was published in PharmAsia News, Oct. 12, 2008.]
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).